Gene therapy developer
Vivet Therapeutics has raised €83M across 2 funding rounds from 7 investors, most recently a round in Jan 2019. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2019-01-01 | Other | €45M | Pfizer | View deal → |
| 2017-05-04 | Series A | €38M | Columbus Venture Partners,HealthCap,Kurma Partners,Novartis Venture Fund,Roche Venture Fund,Ysios Capital | View deal → |
